Treatment of Chickenpox in Infants

Introduction to Treatment

For an 8-month-old child with chickenpox, supportive care is the primary recommended treatment, as antiviral therapy is not routinely indicated in otherwise healthy infants with uncomplicated varicella infection, according to the American Academy of Pediatrics and the Centers for Disease Control and Prevention 1, 2

The Centers for Disease Control and Prevention recommends that antiviral therapy with acyclovir should be considered in specific situations, such as if the infant is immunocompromised or receiving immunosuppressive therapy 1, 2

The American Academy of Pediatrics recommends keeping the child isolated until all lesions have crusted over (typically 5-7 days) to prevent the spread of chickenpox 3
The Centers for Disease Control and Prevention suggests that family members who are susceptible to chickenpox and have been exposed may benefit from varicella vaccine if administered within 3-5 days of exposure, and varicella-zoster immune globulin (VZIG) may be indicated for high-risk exposed individuals without immunity 2, 4, 5

The American Academy of Pediatrics states that most cases resolve without complications within 5-7 days, and follow-up is typically not necessary unless complications develop 3
The American Academy of Family Physicians recommends considering vaccination against varicella once the child reaches 12 months of age if they haven't already received it 4, 6

The Centers for Disease Control and Prevention recommends relieving itching with lukewarm baths with colloidal oatmeal for children with chickenpox 7
The Centers for Disease Control and Prevention suggests ensuring the child receives a second dose of varicella vaccine once fully recovered if they've only had one dose previously, and susceptible family members who have been exposed may benefit from varicella vaccine if administered within 3-5 days of exposure 8, 7

Immunocompromised patients require intravenous acyclovir, as recommended by the American Academy of Pediatrics, due to increased risk of severe varicella 9
Intravenous high-dose acyclovir for 7-10 days is recommended for immunocompromised children, including those with congenital nephrotic syndrome and hypogammaglobulinemia, as per the guidelines from the Nature Reviews Nephrology 9
HIV-infected children in CDC class 1 with CD4 ≥15% may receive varicella vaccine, as suggested by the Pediatrics journal 10

Varicella-zoster immune globulin (VZIG) should be given to susceptible high-risk patients as soon as possible after exposure, effective up to 10 days post-exposure, as recommended by the Nature Reviews Nephrology 9
Prophylactic oral acyclovir (10 mg/kg four times daily for 7 days) within 7-10 days of exposure is recommended if VZIG is unavailable, according to the Nature Reviews Nephrology 9

A two-dose varicella vaccination schedule is recommended, with the first dose at 12-15 months and the second dose at 4-6 years, as suggested by the Pediatrics journal 11

The Centers for Disease Control and Prevention recommends monitoring for bacterial superinfection, particularly invasive group A streptococcal infections, in varicella patients, as these are the most frequent complications requiring hospitalization 12
Infants under 1 year are 6 times more likely to be hospitalized than children aged 5-9 years due to higher complication rates, according to the CDC 12
The CDC advises examining for signs of invasive bacterial infection, including expanding erythema around lesions, purulent drainage, increasing pain or tenderness, and systemic toxicity 12
The American Academy of Pediatrics suggests watching for pneumonia, dehydration, and encephalitis as additional serious complications 12

The CDC recommends varicella-zoster immune globulin (VZIG) for high-risk exposed individuals without immunity, including immunocompromised contacts, pregnant women without evidence of immunity, and specific neonatal populations 13, 14

The American Academy of Pediatrics states that once a child fully recovers from varicella, no additional varicella vaccination is needed, as natural infection provides lifelong immunity 15

Chickenpox can be more severe or life-threatening in immunocompromised patients, causing pneumonia, hepatitis, encephalitis, or hemorrhagic disorders, such as thrombocytopenia or disseminated intravascular coagulopathy, according to the Journal of Crohn's and Colitis guidelines 16
Intravenous high-dose aciclovir (10 mg/kg every 8 hours) for 7-10 days is mandatory for immunocompromised patients with chickenpox and leukopenia, as recommended by the Nature Reviews Nephrology 17
Immunomodulator therapy should be discontinued in severe cases of chickenpox and leukopenia in immunocompromised patients if clinically feasible, as suggested by the Journal of Crohn's and Colitis guidelines 16

In children with compromised immune systems, intravenous high‑dose acyclovir (10 mg/kg every 8 hours) is recommended for a treatment course of 7–10 days to prevent severe varicella complications. This recommendation is supported by the review in Nature Reviews Nephrology (2021)【18】.

Varicella is transmissible from 1–2 days before rash appearance until all lesions have crusted (typically 5–7 days after rash onset). Accordingly, the child should remain isolated until complete crusting to avoid spreading the infection, as outlined in Pediatrics (2007)【19】【20】.

The Centers for Disease Control and Prevention (CDC) recommends that infants whose mothers develop varicella from 5 days before to 2 days after delivery receive prompt intravenous acyclovir (10 mg/kg every 8 hours for 7–10 days) because historical mortality rates have been reported as high as 31 % in this population【21】.

The CDC advises that children who have recovered from natural varicella infection do not require varicella vaccination, as the infection confers lifelong immunity; however, they should continue to receive all other age‑appropriate vaccines, including the first measles‑mumps‑rubella (MMR) dose at 12–15 months of age【22】.